Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00717756 · ClinicalTrials.gov registry record · Phase 2
Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial
A Phase 2 study, sponsored by Brown University.
- Completed
- Registry status
- Phase 2
- Development phase
- 41
- Enrollment target
NCT00717756 is a Phase 2 study that has completed, run by Brown University. The registered enrollment target is 41 participants.
The verdict
NCT00717756, a Phase 2 study, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 41 participants
- Enrollment target
Study Summary
This study will determine whether lenalidomide has activity in patients with advanced liver cancer that have had growth of their cancer after sorafenib.
Interventions
- DRUG lenalidomide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2009-01 |
| Est. Completion | 2014-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00717756
The ClinicalTrials.gov registry entry for NCT00717756 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brown University, which has 231 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which lenalidomide is the first listed.
NCT00717756 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00717756 about?
NCT00717756 is a clinical study titled "Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial". This study will determine whether lenalidomide has activity in patients with advanced liver cancer that have had growth of their cancer after sorafenib.
What is the current status of trial NCT00717756?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 41 participants. The study started on 2009-01. Estimated completion is 2014-01.
What interventions are being tested in trial NCT00717756?
The interventions under investigation include: lenalidomide (DRUG).
Who is sponsoring clinical trial NCT00717756?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.